{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T22:31:40Z","timestamp":1767825100858,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.neulet.2010.03.041","type":"journal-article","created":{"date-parts":[[2010,3,22]],"date-time":"2010-03-22T08:24:18Z","timestamp":1269246258000},"page":"64-68","source":"Crossref","is-referenced-by-count":63,"title":["Valproic acid stimulates clusterin expression in human astrocytes: Implications for Alzheimer's disease"],"prefix":"10.1016","volume":"475","author":[{"given":"Tapio","family":"Nuutinen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiina","family":"Suuronen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anu","family":"Kauppinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antero","family":"Salminen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2010.03.041_bib1","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","article-title":"Transport pathways for clearance of human Alzheimer's amyloid \u03b2-peptide and apolipoproteins E and J in the mouse central nervous system","volume":"27","author":"Bell","year":"2007","journal-title":"J. Cereb. Blood Flow Metam."},{"key":"10.1016\/j.neulet.2010.03.041_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/0-387-23226-5_14","article-title":"Clusterin and Alzheimer's disease","volume":"38","author":"Calero","year":"2005","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.neulet.2010.03.041_bib3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/15216540310001640498","article-title":"Small heat-shock proteins and clusterin: intra- and extracellular molecular chaperones with a common mechanism of action and function?","volume":"55","author":"Carver","year":"2003","journal-title":"IUBMB Life"},{"key":"10.1016\/j.neulet.2010.03.041_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/1568009033481994","article-title":"Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics?","volume":"3","author":"Chen","year":"2003","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.neulet.2010.03.041_bib5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","article-title":"Multiple roles of HDAC inhibition in neurodegenerative conditions","volume":"32","author":"Chuang","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neulet.2010.03.041_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","article-title":"Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors","volume":"34","author":"Duenas-Gonzalez","year":"2008","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.neulet.2010.03.041_bib7","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1124\/mol.106.027912","article-title":"Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain","volume":"70","author":"Faraco","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neulet.2010.03.041_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3233\/JAD-2009-1134","article-title":"Dysregulation of histone acetylation in the APP\/PS1 mouse model of Alzheimer's disease","volume":"18","author":"Francis","year":"2009","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.neulet.2010.03.041_bib9","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproate acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.neulet.2010.03.041_bib10","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1158\/0008-5472.CAN-03-0799","article-title":"Histone deacetylase is a target of valproic acid-mediated cellular differentiation","volume":"64","author":"Gurvich","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.neulet.2010.03.041_bib11","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neulet.2010.03.041_bib12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1357-2725(01)00155-8","article-title":"Clusterin","volume":"34","author":"Jones","year":"2002","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neulet.2010.03.041_bib13","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/ncponc1238","article-title":"Drug insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas","volume":"5","author":"Khan","year":"2008","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"10.1016\/j.neulet.2010.03.041_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2009.197","article-title":"Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease","author":"Kilgore","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2010.03.041_bib15","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1471-4159.2009.06212.x","article-title":"The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain","volume":"110","author":"Kim","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2010.03.041_bib16","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1124\/jpet.107.120188","article-title":"Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action","volume":"321","author":"Kim","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2010.03.041_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.14712\/fb2007053020037","article-title":"Valproic acid, a molecular lead to multiple regulatory pathways","volume":"53","author":"Kostrouchova","year":"2007","journal-title":"Folia Biol."},{"key":"10.1016\/j.neulet.2010.03.041_bib18","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neulet.2010.03.041_bib19","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1523\/JNEUROSCI.0096-06.2006","article-title":"Endogenous \u03b1-synuclein is induced by Valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity","volume":"26","author":"Leng","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2010.03.041_bib20","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1523\/JNEUROSCI.5467-07.2008","article-title":"Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition","volume":"28","author":"Leng","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2010.03.041_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1042\/BJ20051190","article-title":"Up-regulation of the clusterin gene after proteotoxic stress: implication of HSF1-HSF2 heterocomplexes","volume":"395","author":"Loison","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.neulet.2010.03.041_bib22","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1399-5618.2009.00762.x","article-title":"Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect","volume":"11","author":"Mann","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neulet.2010.03.041_bib23","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/jcb.22185","article-title":"Histone deacetylase inhibitors: potential in cancer therapy","volume":"107","author":"Marks","year":"2009","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.neulet.2010.03.041_bib24","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1046\/j.1471-4159.1997.69051995.x","article-title":"Isoform-specific effects of apolipoprotein E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid \u03b2","volume":"69","author":"Martel","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2010.03.041_bib25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0896-6273(90)90342-D","article-title":"Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat","volume":"5","author":"May","year":"1990","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2010.03.041_bib26","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.2174\/138161207782360519","article-title":"Valproic acid as anti-cancer drug","volume":"13","author":"Michaelis","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neulet.2010.03.041_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/bj3280045","article-title":"Stress-induced transcription of the clusterin\/apoJ gene","volume":"328","author":"Michel","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.neulet.2010.03.041_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.brainresrev.2009.05.007","article-title":"Clusterin: a forgotten player in Alzheimer's disease","volume":"61","author":"Nuutinen","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neulet.2010.03.041_bib29","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.neuint.2005.07.007","article-title":"Induction of clusterin\/apoJ expression by histone deacetylase inhibitors in neural cells","volume":"47","author":"Nuutinen","year":"2005","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neulet.2010.03.041_bib30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/cne.903390307","article-title":"Clusterin (SPG-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain","volume":"339","author":"Pasinetti","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neulet.2010.03.041_bib31","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2010.03.041_bib32","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1158\/1078-0432.CCR-08-2785","article-title":"Clinical studies of histone deacetylase inhibitors","volume":"15","author":"Prince","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neulet.2010.03.041_bib33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2174\/156720505774932205","article-title":"A randomized, double-blind, placebo-controlled pilot trial of safety and tolerability of two doses of divalproex sodium in outpatients with probable Alzheimer's disease","volume":"2","author":"Profenno","year":"2005","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neulet.2010.03.041_bib34","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1084\/jem.20081588","article-title":"Valproic acid inhibits A\u03b2 production, neuritic plaque formation, and behavioural deficits in Alzheimer's disease mouse models","volume":"205","author":"Qing","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neulet.2010.03.041_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0065-230X(09)05002-7","article-title":"The role of clusterin (CLU) in malignant transformation and drug resistance in breast carcinomas","volume":"105","author":"Redondo","year":"2009","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.neulet.2010.03.041_bib36","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/npp.2008.229","article-title":"Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model","volume":"34","author":"Ricobaraza","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2010.03.041_bib37","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1677\/ERC-09-0140","article-title":"The clusterin paradigm in prostate and breast carcinogenesis","volume":"17","author":"Rizzi","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.neulet.2010.03.041_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1677\/jme.0.0130069","article-title":"Regulators for the rat clusterin gene: DNA methylation and cis-acting regulatory elements","volume":"13","author":"Rosemblit","year":"1994","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.neulet.2010.03.041_bib39","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/1357-2725(95)00027-M","article-title":"Clusterin: physiologic and pathophysiologic considerations","volume":"27","author":"Rosenberg","year":"1995","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neulet.2010.03.041_bib40","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1046\/j.1471-4159.2003.01788.x","article-title":"Microglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: opposite effects of lipopolysaccharide","volume":"85","author":"Saura","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2010.03.041_bib41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biopsych.2006.06.036","article-title":"Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse","volume":"62","author":"Schroeder","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2010.03.041_bib42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00002512-200320020-00005","article-title":"Drug treatment of epilepsy in elderly people. Focus on valproic acid","volume":"20","author":"Stephen","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1016\/j.neulet.2010.03.041_bib43","first-page":"942","article-title":"Divalproex sodium in nursing home residents with possible or probable Alzheimer disease complicated by agitation: a randomized, controlled trial","volume":"13","author":"Tariot","year":"2005","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neulet.2010.03.041_bib44","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jnutbio.2007.08.002","article-title":"Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon","volume":"19","author":"Waldecker","year":"2008","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.neulet.2010.03.041_bib45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0968-0004(99)01534-0","article-title":"Clusterin is a secreted mammalian chaperone","volume":"25","author":"Wilson","year":"2000","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neulet.2010.03.041_bib46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brainresbull.2009.09.003","article-title":"Valproic acid as a promising agent to combat Alzheimer's disease","volume":"81","author":"Zhang","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neulet.2010.03.041_bib47","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1073\/pnas.93.9.4229","article-title":"Glycoprotein 330\/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers","volume":"93","author":"Zlokovic","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2010.03.041_bib48","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/77397","article-title":"Clearance of amyloid \u03b2-peptide from brain: transport or metabolism?","volume":"6","author":"Zlokovic","year":"2000","journal-title":"Nat. Med."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394010003381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394010003381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T16:51:39Z","timestamp":1739983899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394010003381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0304394010003381"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2010.03.041","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}